Evidence map›Paper›PMID 42141118›Full record

ArticleNature biotechnology2026

DNA-guided CRISPR-Cas12 for cellular RNA targeting.

Carlos Orosco, Boyu Huang, Santosh R Rananaware, August P Bodin, Ivy Browning, Anne Fang, Michael P Baugh, Ian H Lange, Yasmin B Elhabashy, Mahika Balaraju and 7 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Architecture of a DNA-guided Cas12a.Nature structural & molecular biology · 2026
    Article
  2. CRISPR-based ex vivo gene editing of donor organs.Nature reviews bioengineering · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Carlos Orosco *Department of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0009-4865-2300
Boyu Huang *Department of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0003-2646-7656
Santosh R Rananaware *Department of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0001-8789-5799
August P BodinDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0006-8132-8818
Ivy BrowningCasNx, LLC, Alachua, FL, USA.ORCID http://orcid.org/0009-0003-5587-8435
Anne FangDepartment of Chemical Biology, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0007-2050-5099
Michael P BaughDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0008-8784-5749
Ian H LangeDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0009-8345-8220
Yasmin B ElhabashyDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0001-7836-6622
Mahika BalarajuDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA.
Jordan G LewisDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0006-7339-0056
Nayan H ShahDepartment of Microbiology and Cell Sciences, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0007-2749-5276
Michael P HannaDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.
Sarah J FlanneryDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0009-0008-0436-4975
Katelyn S MeisterDepartment of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-4642-1949
Vedant KaralkarDepartment of Computer Science, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0002-0623-0582
Piyush K JainDepartment of Chemical Engineering, University of Florida, Gainesville, FL, USA. Jainp@ufl.edu.ORCID http://orcid.org/0000-0001-7153-442X

Funding

Discovery and engineering of CRISPR/Cas systemsR35GM147788 · NIGMS · UNIVERSITY OF FLORIDA · PI Piyush K Jain · 2022 to 2026
$1.8M
A rapid CRISPR-based self-testing platform for early detection of HIVR61AI181016 · NIAID · UNIVERSITY OF FLORIDA · PI Piyush K Jain · 2024 to 2026
$1.3M
Rapid detection of Hepatitis C virus using CRISPR/CasR21AI156321 · NIAID · UNIVERSITY OF FLORIDA · PI JAIN, PIYUSH K · 2021 to 2022
$419k
Rapid point-of-care detection of Hepatitis C viral RNA using multiplexed CRISPR/Cas platformsR21AI168795 · NIAID · UNIVERSITY OF FLORIDA · PI JAIN, PIYUSH K · 2022 to 2023
$419k
NIAID NIH HHS R21 AI156321NIAID NIH HHS R21 AI168795NIAID NIH HHS R61 AI181016NIGMS NIH HHS R35 GM147788U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI156321U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI168795U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R61AI181016U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM147788
6 · The paper itself

Abstract

Here, we present ΨDNA, a DNA-based guide that enables RNA targeting by Cas12 nucleases, overcoming the traditional reliance on RNA-guided systems. We engineer ΨDNA to mimic a CRISPR RNA (crRNA) scaffold in reverse orientation, allowing AsCas12a and Cas12i1 to recognize RNA and trigger strong single-stranded DNA trans-cleavage for sensitive detection of diverse RNA species, including 100% accurate hepatitis C virus RNA detection in clinical samples. ΨDNA also achieves 70-95% multiplex knockdown of endogenous intracellular RNA transcripts through ribosome stalling across multiple human cell lines. Mechanistic studies reveal that activity depends on a stem loop that stabilizes a catalytically competent Cas12-ΨDNA-RNA complex. Lastly, codelivery of crRNA and ΨDNA enables simultaneous DNA editing and RNA knockdown with a single effector and modular fusions of different enzymes to AsCas12a extend ΨDNA to RNase H-mediated RNA degradation and METTL3-based epitranscriptomic editing. Together, ΨDNA guides constitute an adaptable toolkit that extends Cas12 systems beyond genome editing and diagnostics to enable precise, programmable control of cellular transcriptomes and their epitranscriptomic marks.

Identifiers

PMID42141118
PMCPMC13403136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.